US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
Haad Thip Public Company Ltd (EM) (HAATF) 銘柄情報

Haad Thip Public Company Ltd (EM) (HAATF)

0.4838

0.00

(0.00%)

終了 6月15日 5:00AM

Haad Thip Public Company Ltd (EM) (HAATF) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.4838

( - )

買値

0.00

売値

0.00

出来高

-

0.00 日の範囲 0.00

0.4838 52 週間の範囲 0.4838

時価総額

前日終値

0.4838

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 206,457

発行済株式数

401,920,000

配当利回り

PER

10.56

1 株当たり利益 (EPS)

1.45

歳入

6.87B

純利益

584.69M

Haad Thip Public Company Limited, together with its subsidiaries, manufactures and distributes soft drinks in Thailand. The company operates through Carbonated Soft Drink and Real Estate segments. It provides sparkling beverages under the Coca-Cola, Fanta, and Sprite trademarks; and non-carbonated/s... Haad Thip Public Company Limited, together with its subsidiaries, manufactures and distributes soft drinks in Thailand. The company operates through Carbonated Soft Drink and Real Estate segments. It provides sparkling beverages under the Coca-Cola, Fanta, and Sprite trademarks; and non-carbonated/still beverages under the Minute Maid and Namthip Drinking Water trademarks. The company also manufactures and distributes plastic bottles and semi-finished plastic bottles; and provides plastic bottle blowing services, as well as develops real estate properties. In addition, it provides food and snack products under Green Nut, Taro, Tabi, and Norita brands; personal and home care products; and own restaurants. The company was founded in 1969 and is based in Songkhla, Thailand. 詳細を表示

セクター

Consumer Staples

業界

Beverages - Non-alcoholic

ウェブサイト

www.haadthip.com

本社

Songkhla, Thailand

設立

1969

Haad Thip Public Company Ltd (EM) is listed in the Consumer Staples sector of the その他OTC with ticker HAATF. The last closing price for Haad Thip Public (EM) was US$0.48. Over the last year, Haad Thip Public (EM) shares have traded in a share price range of US$ 0.4838 to US$ 0.4838.

Haad Thip Public (EM) currently has 401,920,000 shares in issue. The market capitalisation of Haad Thip Public (EM) is US$194.45 million. Haad Thip Public (EM) has a price to earnings ratio (PE ratio) of 10.56.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0.4838	0.4838	0.4838	0	0	CS
26	0	0	0.4838	0.4838	0.4838	0	0	CS
52	0	0	0.4838	0.4838	0.4838	0	0	CS
156	-0.5212	-51.8606965174	1.005	1.005	0.4838	88	0.4838	CS
260	-0.5212	-51.8606965174	1.005	1.005	0.4838	1038	0.97046265	CS

HAATF - Frequently Asked Questions (FAQ)

What is the current Haad Thip Public Company Ltd (EM) share price?

The current share price of Haad Thip Public Company Ltd (EM) is US$ 0.4838

How many Haad Thip Public Company Ltd (EM) shares are in issue?

Haad Thip Public Company Ltd (EM) has 401,920,000 shares in issue

What is the market cap of Haad Thip Public Company Ltd (EM)?

The market capitalisation of Haad Thip Public Company Ltd (EM) is USD 194.45M

What is the 1 year trading range for Haad Thip Public Company Ltd (EM) share price?

Haad Thip Public Company Ltd (EM) has traded in the range of US$ 0.4838 to US$ 0.4838 during the past year

What is the PE ratio of Haad Thip Public Company Ltd (EM)?

The price to earnings ratio of Haad Thip Public Company Ltd (EM) is 10.56

What is the cash to sales ratio of Haad Thip Public Company Ltd (EM)?

The cash to sales ratio of Haad Thip Public Company Ltd (EM) is 0.9

What is the registered address of Haad Thip Public Company Ltd (EM)?

The registered address for Haad Thip Public Company Ltd (EM) is 87/1, Kanchanavanich Road, Songkhla, 90250

What is the Haad Thip Public Company Ltd (EM) website address?

The website address for Haad Thip Public Company Ltd (EM) is www.haadthip.com

Which industry sector does Haad Thip Public Company Ltd (EM) operate in?

Haad Thip Public Company Ltd (EM) operates in the Beverages - Non-Alcoholic sector

Hi_Lo

This will trade forever as long as there is volume. Bidding here at rock bottom. This will never be a FINRA delete as long as there is volume.
NV SoS a new entity will scoop this up and finish the Sharp legend 🚀
Google Gemini

https://g.co/gemini/share/4e20adf2ce7

Gmenfan

Gmenfan 3分前

SkyLimit2022

SkyLimit2022 3分前

theorysuit,

Is the FDA “pumping” too by approving the new
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177686613 P2 combo trial to proceed? 🙄

“Authorization of a Phase 2 trial represents more than permission to continue development

Steady_T

Steady_T 4分前

Why would you drive a company in financial straights into bankruptcy by spending money to get licensed in a market that it can't support?

At the time the UK application was filed the approval decision was expected in a reasonable time and that would have allowed the company to obtain

WarMachine

WarMachine 4分前

If the deal sticks this time $SCO will at minimum double.

Gmenfan

Gmenfan 5分前

InfiniteHaven63

InfiniteHaven63 6分前

Happy Sunday to all my BLEG peeps!

RIGATONI

RIGATONI 6分前

~DTREF .09...

Reminder and this new article...

Again, China is behind this drop imo...

June 9th..

Gmenfan

Gmenfan 6分前

Oh dear................ :-)

joe botts

joe botts 8分前

Lol! Whew lunch and Applebee's for dinner money.

ddls

All this enthusiasm for a stock that trades 10 or less times a day. More posts than trades....hmmmmmmm!

joe botts

joe botts 10分前

No way what about Wertheim! Lmao

BIOChecker4

BIOChecker4 12分前

“CROs were responsible for the data and they are not combing through their work.“

You could not possibly know this. You are making a supposition that is not supported by any evidence.

As for no need to check every nook and cranny, the exact opposite is true. Every bit

luckydude777

luckydude777 14分前

Sure hope the "deal" is legit. Will be nice if it is.

BIOChecker4

BIOChecker4 16分前

Your logic is flawed. How would Dr. K. Know the AD data are good when the trials that generated the data were flawed? This is the reason large, well designed phase 3 trials are necessary and will be required by drug regulators.

theorysuit

theorysuit 16分前

Don't worry all the people posting on here are paid pumps. That's why they are apologizing and assigning blame to anyone but nwbo. No sane investor would be happy with this lying POS company who has failed in so many ways.

These small pumps for the company to offload thei

NYATC

Let hope they don’t “screw the pooch”. You know that one? 😆

AJH92

$ECOX Overview - Updated June 13, 2026

New CEO: Richard C Hawkins wef April 2, 2025

Reverse Merger With Kepler GTL

Letter of Intent to Combine [source: PR February 17, 2026]

- On February 12, 2026 entered into a non-binding Letter of Intent

ddls

This stock is finished, done, the end...but you go ahead and dream of something else.

HyGro

NWBO didn't have much choice. FDA took a pass, EU is more difficult, so UK looked like their best option.

The EU requires interaction with multiple bodies: EMA scientific assessment via rapporteurs, CHMP opinion, and then EC legal decision, plus subsequent national pricing/HTA negot

nwsun

Hopefully we all make a big gain on another investment and we can use sflm as a full write off against those gains.

theorysuit

theorysuit 21分前

Oh sure blame the mhra for it taking this long. Where are the other applications/submissions LP In promised 3 years ago. Do you want to blame that on MHRA too? Blame anyone else is their mantra .......lmfao. Is that why LP says they won't update on status? Protesting the rejection?Lmfao at

William777

William777 21分前

(Nutanomics) also known as NNI produced and branded its own product line, and began to sell to the retail outlets and to the public. NNI has also produced formulas for hundreds of other companies. Trademarks, Tradenames, and Patents: NNI®, NutraNomics®, HEC®, Health Education Corporation®, AES®, Ass

Vexari

Vexari 21分前

Brian's Song (1971)

This highly acclaimed winner of five Emmy Awards

It's the true story of a special relationship between two professional football players

Gale Sayers (Billy Dee Williams) and Bria

Haad Thip Public (EM)

Cementos Argos (ID)

Selina Hospitality (EM)

Molson Coors Beverage

Taylor Maritime

Settle ISE FX Mexican Pe...

AGROB Immobilien

International bonds 3.12...

Invesco Markets II Plc I...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。